BIS is seeking public comments on the impact on commercial activities and interests of chemical, biotechnology, and pharmaceutical firms on the proposed additions to "Schedule 1" in the "Annex on Chemicals" to the CWC. The purpose of this Notice of Inquiry is to collect information to assist BIS in assessing the likely impact on US industry of the proposed addition of five chemical facilities to "Schedule 1" in the "Annex on Chemicals". Comments are due to BIS by September 13, 2019.

See TCD's publication -- Production of Intermediate Schedule 1 Chemicals and Schedule 1 "Captive Use" Declaration Guidance" -- for useful guidance on production of intermediate Schedule 1 chemicals and Schedule 1 chemicals in a captive use situation.

Your facility may be subject to a CY 2020 ADAA requirement, if its projected activities involving Schedule 2 and/or 3 chemicals will exceed specified threshold quantities. See Parts 713 and 714 of the CWC Regulations for specific declaration requirements.

Review your facility's CY 2019 ADAA submitted last year to determine if the projected activities adequately reflect current business projections through the end of the year. If you anticipate changes to your projected CY 2019 activities, you may be required to submit a Declaration on Additionally Planned Activities (DAPA). The specific requirements for DAPAs are outlined in Sections 713.4 and 714.3 of the CWC Regulations for Schedule 2 and Schedule 3 chemicals, respectfully.

Click here to access the paper declaration and report forms, which are in PDF data enterable format. The forms must be signed and sent to TCD via US mail or delivered via carrier to the below address.